FibroBiologics (FBLG) Total Debt (2022 - 2026)

FibroBiologics (FBLG) has reported Total Debt for 4 consecutive years, with $124000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt fell 98.46% year-over-year to $124000.0; the trailing twelve-month figure through Jun 2026 stood at $124000.0 (down 98.46% YoY), and the FY2025 full-year result was $11.6 million, up 16.0% from the prior year.
• Total Debt slipped to $124000.0 in Q2 2026 per FBLG's latest filing, from $246000.0 in the prior quarter.
• Across five years, Total Debt topped out at $11.6 million in Q4 2025 and bottomed at $115000.0 in Q3 2024.
• Historically, Total Debt has averaged $4.7 million across 4 years, with a median of $5.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Total Debt jumped 8334.78% in 2025, then sank 98.46% in 2026.
• Over 4 years, Total Debt stood at $5.5 million in 2022, then jumped by 83.45% to $10.0 million in 2024, then climbed by 16.0% to $11.6 million in 2025, then sank by 98.93% to $124000.0 in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $124000.0, $246000.0, and $11.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.